is it normal to get sulphur burps at week 47
Update, and the title has the headline: is it normal to get sulphur burps at week 47.
Stopped for cost reasons. Appetite came back at about week 17, well before the scale moved, exactly as this board said it would.
There is very little published guidance on stopping specifically, which is exactly why board consensus here should carry less weight than usual and a clinician conversation should carry more.
Please do not ask me what dose you should be on. I genuinely do not know and neither does anyone else here.
best — the order this archive was captured in
Nothing on this board is a taper schedule, and no member can write one for another. What can be shared is what people watched and what they observed.
Removed the taper schedule written for another member. Describe your own experience instead.
Cosigning that cost and supply are legitimate reasons. Most of the stopping threads here are one of those two.
Push back: that is a taper schedule aimed at another member and this board does not host those.
Not convinced. Two weeks of stable weight is not evidence of anything yet.
write down where you are before you change anything
decide what you are watching for before you stop
Went back on after eight months away. Nobody here made me feel bad about it, which mattered more than I expected.
Same. A quiet fortnight after stopping tells you very little; the interesting part starts later.
This. Decide in advance what you are watching for. Deciding in the middle of it is much harder.
Careful — interval stretching and dose reduction are different interventions and your post uses them interchangeably.
cost and supply are the two most common reasons and both are legitimate
Had the conversation with a clinician before stopping rather than after. Considerably easier that way round.
With a week-long half-life, exposure declines over several weeks after the last dose rather than stopping with it. The lag is why the first fortnight is uninformative.
Withdrawal studies across this class consistently show substantial regain after discontinuation, with appetite typically returning before weight changes. That is a description of the pharmacology of a chronic condition.